Regeneron Pharmaceuticals
REGN
#231
Rank
โ‚น6.577 T
Marketcap
โ‚น59,853
Share price
-0.90%
Change (1 day)
-14.48%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): โ‚น3,085

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น3,186. In 2022 the company made an earnings per share (EPS) of โ‚น3,456 a decrease over its 2021 EPS that were of โ‚น6,520.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น3,085-10.74%
2022โ‚น3,456-47%
2021โ‚น6,520133.36%
2020โ‚น2,79469.13%
2019โ‚น1,652-14.44%
2018โ‚น1,931100.71%
2017โ‚น961.9531.78%
2016โ‚น729.9938.96%
2015โ‚น525.3272.55%
2014โ‚น304.45-17.55%
2013โ‚น369.26-44.98%
2012โ‚น671.15-422.54%
2011-โ‚น208.0892.13%
2010-โ‚น108.3049.41%
2009-โ‚น72.49-15.84%
2008-โ‚น86.13-36.88%
2007-โ‚น136.45-9.6%
2006-โ‚น150.944.12%
2005-โ‚น144.97-323.68%
2004โ‚น64.81-135.51%
2003-โ‚น182.50-24.38%
2002-โ‚น241.3456.35%
2001-โ‚น154.36187.3%
2000-โ‚น53.73-16%
1999-โ‚น63.96177.78%
1998-โ‚น23.03-35.71%
1997-โ‚น35.82-68.42%
1996-โ‚น113.42

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น1,207-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น350.50-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,574-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1,201-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น318.94-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น271.21-91.49%๐Ÿ‡ซ๐Ÿ‡ท France